Monday, July 10, 2006

Is the FDA doing it's job?

From published reports:
Drug makers routinely fail to file status reports with the federal government that show what kind of progress they have made in conducting safety studies.

That's the conclusion of a review from the inspector general for the Health and Human Services Department. Investigators found that 35 percent of status reports that drug makers were supposed to file in fiscal year 2004 were missing entirely or contained no information on agreed-to studies.

"Monitoring postmarketing study commitments is not a top priority at the (Food and Drug Administration)," the investigators concluded.
More ...